Skip to content

Moderna MRNA Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin178.2%-32.0pp210.2%+0.6pp209.6%-19.2pp228.8%+19.5pp209.4%+31.7pp
Operating margin-573%-36.0pp-537%-36.2pp-500.8%-102pp-398.7%-14.4pp-384.3%-17.5pp
Net margin-522.6%-37.9pp-484.8%-35.1pp-449.6%-91.6pp-358.1%+26.2pp-384.2%+14.4pp
EBITDA margin-535.3%-31.5pp-503.8%-31.0pp-472.8%-99.2pp-373.6%-18.1pp-355.5%-22.7pp
Returns
Return on equity-122.2%-7.2pp-115%-0.1pp-114.9%-10.1pp-104.8%+15.0pp-119.8%+9.7pp
Return on assets-91%-3.6pp-87.4%+0.6pp-88%-8.5pp-79.5%+11.4pp-90.9%+7.5pp
Return on invested capital-145.8%-7.4pp-138.4%+0.1pp-138.5%-10.9pp-127.7%+3.4pp-131.1%+0.7pp
Efficiency
Asset turnover0.7×0.0×0.7×-0.1×0.8×-0.1×0.9×0.0×0.0×
Inventory turnover43.4×+3.4×40×-2.6×42.6×+0.8×41.7×+2.5×39.2×+2.6×
Liquidity
Current ratio13.6×-1.8×15.4×-0.4×15.7×-0.5×16.2×-0.2×16.4×+0.2×
Quick ratio13.3×-1.8×15.1×-0.4×15.4×-0.5×15.9×-0.2×16.1×+0.2×
Cash ratio3.6×-0.2×3.8×+0.4×3.4×-0.1×3.5×-0.2×3.7×+0.1×
Leverage
Debt-to-equity0.5×+0.1×0.4×+0.1×0.3×0.0×0.3×0.0×0.4×0.0×
Debt-to-assets0.4×+0.1×0.3×+0.1×0.2×0.0×0.3×0.0×0.3×0.0×
Per Share
Book value per share$89.14-7.6%$96.46-6.0%$102.61-5.5%$108.58-5.5%$114.86-6.1%
Valuation
Market capitalization$52.08B+21.4%$42.9B-9.5%$47.38B-24.8%$63.02B-35.8%$98.16B-23.3%
Enterprise value$49.35B+23.7%$39.9B-10.3%$44.48B-26.1%$60.23B-36.4%$94.68B-24.0%
Price / sales22.9×+5.6×17.2×+1.0×16.3×-0.6×16.8×-5.6×22.5×-4.5×
Price / book6.2×+1.6×4.6×-0.1×4.7×-1.1×5.8×-2.8×8.6×-2.1×
EV / sales21.6×+5.6×16×+0.7×15.3×-0.7×16×-5.6×21.5×-4.6×
Earnings yield-99.4%+14.8pp-114.1%-2.2pp-111.9%-21.5pp-90.4%-14.6pp-75.8%-15.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Moderna's profit margins?
Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
Where do Moderna's ratios come from?
Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.